Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 1Phase 1 1

Status

Recruiting 7Not yet recruiting 4Active not recruiting 3Terminated 1Completed 1

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 153Neoplasms 112Carcinoma, Non-Small-Cell Lung 85Colorectal Neoplasms 81Prostatic Neoplasms 80Lung Neoplasms 73Leukemia, Myeloid, Acute 50Carcinoma, Hepatocellular 48Pancreatic Neoplasms 46Neoplasm Metastasis 40Multiple Myeloma 37Recurrence 35Triple Negative Breast Neoplasms 29Squamous Cell Carcinoma of Head and Neck 28Precursor Cell Lymphoblastic Leukemia-Lymphoma 27Melanoma 27Glioblastoma 27Ovarian Neoplasms 26Brain Neoplasms 26Uterine Cervical Neoplasms 25Head and Neck Neoplasms 25Stomach Neoplasms 24Rectal Neoplasms 24Small Cell Lung Carcinoma 22Carcinoma, Renal Cell 20Lymphoma, B-Cell 19Glioma 19Lymphoma, Follicular 18Lymphoma 18Endometrial Neoplasms 18

Interventions

alkaloid GB18 1Fecal Microbiota Transplantation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Not yet recruiting × Cachexia × 90 days × Clear all
NCT07565415 2026-05-04

Nanocrystalline Megestrol Acetate Versus Placebo for Anorexia in Patients With Unresectable Hepatocellular Carcinoma Receiving TACE Combined With Targeted and Immunotherapy

Nanfang Hospital, Southern Medical University

Phase 2 Not yet recruiting
88 enrolled
Gastrointestinal

Anorexia, Cachexia, Carcinoma, Hepatocellular, Malnutrition

NCT07533227 2026-04-16

FMT-CACH

Changzhou No.2 People's Hospital

Phase 2 Not yet recruiting
66 enrolled

Cachexia, Neoplasms

NCT07530666 2026-04-15

Study of the Safety and Efficacy of DS010 in Patients With Cancer Cachexia

Dartsbio Pharmaceuticals Ltd.

Phase 1/2 Not yet recruiting
58 enrolled

Cachexia, Neoplasms

NCT07519564 2026-04-09

A Phase I Clinical Study to Evaluate the PK, PD, Efficacy, and Safety of GB18 Injection in Patients With Tumor Cachexia

Kexing Biopharm Co., Ltd.

Phase 1 Not yet recruiting
18 enrolled

Cachexia, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡